🌿 molecules, memory, and measured truth
Roots to remedies
What important medicines came from, what they are trying to achieve, and what nature really offers beside them.
Plants, fungi, microbes, and the human body are extraordinary chemists. Chinese medicine, Western herbal medicine, and laboratory pharmacology have each noticed parts of that living library. This shelf follows the thread without crowning a winner in advance.
Nature starts many stories. Evidence decides each use.
Nature is a living chemical library
Plants, fungi, microbes, and human physiology have supplied exact medicines, molecular starting points, and biological targets. That evolutionary history is a reason to study nature deeply, not a verdict that every whole organism or crude preparation is safe for humans. nccih-natural nci-natural-products
Origin is not outcome
Natural, extracted, fermented, semisynthetic, fully synthetic, and recombinant describe lineages and manufacture. Benefit and harm still depend on the exact molecule or mixture, exposure, route, population, condition, and evidence. nccih-natural who-traditional
Bioavailability is measured
Bioavailability is the rate and extent at which an active ingredient or active part becomes available at its site of action. Higher exposure is not automatically better; it can strengthen toxicity as well as benefit, and a number from one extract cannot be transferred to a tea, powder, or another formulation. fda-bioavailability ema-herbal-biopharm
Tradition and trial answer different questions
A traditional record can preserve identity, preparation, cultural meaning, and long observation. Clinical studies ask whether one defined intervention changes a defined outcome. Mindicraft keeps both forms of knowledge visible and never silently turns one into the other. who-traditional nccih-tcm
Chinese medicine is not a swap list
Chinese materia medica distinguishes species, plant part, processing, formulas, and traditional pattern context. Evidence for isolated berberine, ephedrine, or artemisinin does not automatically validate a whole herb, a different preparation, or a formula, and a traditional pattern is not silently translated into a biomedical diagnosis. nccih-tcm hk-ephedra
Bencao is a materia-medica lineage
Chinese bencao literature preserves an evolving practice of identifying, describing, preparing, combining, and evaluating medicinal materials. It is not a timeless list of modern drug substitutes, and the modern regulatory term botanical drug adds a different requirement: a defined product with controlled identity, manufacture, and evidence. unesco-bencao fda-botanical who-traditional
Pharmacy makes preparations accountable
Across apothecary history and chemical medicine, pharmacy has meant more than possessing a natural material: identity, amount, preparation, record, skilled judgement, and responsibility make an intervention intelligible. Modern evidence adds new controls, but the bridge from material to accountable preparation is older than modern industry. sciencehistory-apothecaries ncbi-paracelsus who-traditional
Living knowledge has particular stewards
FNHA describes medicine across distinct BC First Nations; Te Papa's named account describes Rongoā Māori in its own context. Mindicraft treats these as separate living relationships and public description as no blanket permission. Attribution, consent, and benefit-sharing are editorial commitments guided by WIPO's framework, not a claim that one legal rule governs every people or place. fnha-medicines tepapa-rongoa wipo-traditional-knowledge
25 medicine lineages
- pain inflammation and clotting Aspirin and willow: a salicylate lineage, not the same platelet medicine Willow helped reveal salicylate chemistry. Aspirin is acetylsalicylic acid, a deliberately acetylated medicine whose irreversible platelet effect is not reproduced by an ordinary willow preparation. willow bark — Promising, uncertain
-
type two diabetes
Metformin, goat's rue, purified berberine, and Huáng Lián: four distinct materials
Goat's rue belongs to metformin's biguanide history but does not contain metformin. Purified berberine has limited human diabetes evidence; whole Huáng Lián is a separate Chinese materia medica and cannot inherit that evidence.
goat's rue — Traditional use recorded
purified berberine — Promising, uncertain
Huáng Lián rhizome — Not established or conflicting - cholesterol and cardiovascular risk Lovastatin and red yeast rice: the same molecule can still mean a different product Monacolin K in red yeast rice is chemically identical to lovastatin. That makes this an exact-molecule lineage, while variable monacolin content, other constituents, contamination, and formulation prevent automatic product equivalence. red yeast rice — Supported for this exact use
- malaria Artesunate and Qing Hao: a Chinese discovery lineage that depends on exact formulation Qing Hao led to artemisinin, and artemisinin led to semisynthetic artesunate. The lineage is direct and profound; raw Artemisia material is still not equivalent to quality-assured artesunate or combination malaria treatment. Qing Hao — Not established or conflicting
- sympathetic nervous system and congestion Ephedrine, pseudoephedrine, and Ma Huang: exact alkaloids inside a variable herb Ma Huang naturally contains ephedrine-family alkaloids, including molecules used as medicines. Exact identity is real; a multialkaloid stem preparation still differs from a labelled single-ingredient product in exposure, purpose, and risk. Ma Huang — Human exposure studied
- heart failure and atrial fibrillation Digoxin and foxglove: a plant molecule made measurable at a very narrow margin Digoxin is a cardiac glycoside obtained from woolly foxglove. Purification does not make it gentle; it makes an exact, narrow-therapeutic-index molecule measurable while whole foxglove remains an unpredictable and potentially fatal mixture. woolly foxglove — Evidence of harm
- anticoagulation and thrombosis Warfarin and moldy sweet clover: poisoning revealed a controllable anticoagulant target Spoiled sweet-clover forage formed dicoumarol and caused cattle to bleed. Warfarin is a later synthetic analogue, not a compound found in ordinary sweet clover and not a reason to treat medicinal Melilotus as natural anticoagulation. sweet clover and spoiled sweet-clover forage — Traditional use recorded
- depression and related disorders Fluoxetine and St. John's wort: a condition-level comparison, not a shared lineage Fluoxetine is a fully synthetic selective serotonin reuptake inhibitor. Defined St. John's wort extracts have human depression evidence, but they are chemically distinct, product-dependent, and unusually prone to consequential drug interactions. St. John's wort — Promising, uncertain
-
pain inflammation and osteoarthritis
Ibuprofen, ginger, and turmeric: shared pain questions without a shared molecule
Ibuprofen is a fully synthetic NSAID with no documented ginger or turmeric lineage. Defined ginger and turmeric extracts have been studied for knee osteoarthritis symptoms, but neither is a natural form of ibuprofen.
ginger — Promising, uncertain
turmeric — Promising, uncertain -
bacterial infection and wound care
Amoxicillin, Penicillium, garlic, and honey wound care: three different relationships
Amoxicillin is a semisynthetic descendant of fungal penicillin. Penicillium is its biological precursor lineage, garlic is not, and heterogeneous topical honey wound studies do not establish systemic antibiotic equivalence.
penicillin-producing Penicillium — Source, not an intervention
garlic — Not established or conflicting
topical honey in wound-care studies — Promising, uncertain - diabetes and insulin deficiency Recombinant human insulin: nature's own signal, made as a controlled biologic Regular recombinant human insulin has the same amino-acid sequence as pancreatic human insulin. It is made by engineered microbes because endogenous insulin is a physiological signal, not a harvestable remedy; no herb supplies a clinical replacement for absent insulin. endogenous human insulin — Source, not an intervention
- cancer chemotherapy Paclitaxel and yew: an exact natural cancer drug separated from a poisonous tree Paclitaxel was isolated intact from Pacific yew bark and remains the same natural molecule when produced through controlled semisynthetic routes. Whole yew is not cancer therapy, and human ingestion of yew material is documented to cause dangerous poisoning. Pacific yew and other Taxus species — Evidence of harm
- severe pain and opioid risk Morphine and opium: the same plant alkaloid, separated from an unstandardised mixture Morphine is an unchanged natural molecule isolated from opium-poppy latex. Raw opium is a chemically variable source material; pharmaceutical identity does not remove opioid danger, and botanical origin does not make exposure controllable. opium-poppy latex — Evidence of harm
-
local anesthesia
Lidocaine, coca, and cocaine: one discovery history, three different interventions
Cocaine from coca was the first clinical local anesthetic and opened a pharmacological path to later synthetic agents. Lidocaine is chemically distinct; coca leaf, regulated nasal cocaine, and lidocaine injection have separate purposes, exposure, and risks.
coca leaf — Traditional use recorded
purified cocaine — Supported for this exact use - blood pressure heart and kidney disease Captopril and jararaca venom: a venom peptide became an enzyme-design clue A peptide from Bothrops jararaca venom helped reveal angiotensin-converting enzyme as a blood-pressure target. Captopril is a small, fully synthetic molecule designed from that biochemical clue; it is not diluted venom and venom contains no captopril. purified jararaca-venom peptide design lead — Preclinical only
- cancer chemotherapy Vincristine and Madagascar periwinkle: the exact plant alkaloid is not the whole plant Vincristine is an unchanged alkaloid obtained from Madagascar periwinkle and formulated as an intravenous cancer medicine. Whole plant material is not the sterile measured injection and cannot inherit the purified drug's leukemia evidence. Madagascar periwinkle — Source, not an intervention
- hormonal contraception Norethindrone and Mexican yam: a plant steroid feedstock transformed into contraception Diosgenin from Mexican yam made industrial steroid synthesis practical, and that chemical platform led to norethindrone. Raw yam contains neither norethindrone nor a contraceptive product; many controlled transformations stand between plant feedstock and medicine. diosgenin from Mexican Dioscorea feedstock — Source, not an intervention
- nutrition and vitamin c deficiency Vitamin C and food: the same molecule, with food and formulation still mattering Plants make vitamin C, and industrial synthesis can make the same L-ascorbic-acid molecule. In a matched kiwifruit study their measured bioavailability was comparable, so natural origin did not create a superior molecule; the surrounding food and product remain different. gold kiwifruit in the matched human study — Human exposure studied
- falciparum malaria Quinine and cinchona: the same antimalarial alkaloid, not the same intervention Cinchona bark is the natural source of quinine and shaped malaria history. The cited quinine sulfate capsule is a defined product for one narrow indication; the historical bark account is not evidence that a bark preparation is the same intervention. cinchona bark — Traditional use recorded
- parasitic infections Ivermectin and avermectin: a soil-microbe discovery followed by semisynthesis A Streptomyces fermentation supplied avermectin, then chemical modification produced ivermectin. The soil organism, culture broth, precursor, oral tablet, and veterinary products are different materials with different evidence. purified avermectin from Streptomyces fermentation — Source, not an intervention
- transplantation and immunosuppression Cyclosporine and fungal fermentation: the same molecule, formulations that are not interchangeable A fungus produces cyclosporine itself, but a fungal culture is not a medicine. Even two pharmaceutical cyclosporine capsule forms can differ enough in bioavailability that the label says they are not interchangeable. cyclosporine-producing fungal culture — Source, not an intervention
- parkinson disease Carbidopa–levodopa and Mucuna: the same levodopa molecule, not the same treatment product Mucuna pruriens seeds contain levodopa, and small trials have studied identified roasted-seed powders. Pharmaceutical carbidopa–levodopa adds a second active molecule and controlled release, so shared levodopa does not make the products interchangeable. identified roasted Mucuna seed powder — Promising, uncertain
- anticoagulation and extracorporeal care Heparin and porcine mucosa: a purified natural mixture, not one molecule Unfractionated heparin is a heterogeneous family of animal-made polysaccharide chains. Purification, source control, sterile formulation, biological potency assay, and monitoring are not extras; together they make the tissue-derived material a usable anticoagulant medicine. heparin chains from porcine intestinal mucosa — Source, not an intervention
- cancer chemotherapy Etoposide and mayapple: a plant natural product reshaped into a topoisomerase medicine Etoposide is a semisynthetic derivative of podophyllotoxin, a natural substance that NCI identifies as extracted from American mayapple. The related structures remain different products, and neither mayapple nor podophyllotoxin inherits the injection's oncology evidence. podophyllotoxin from American mayapple — Source, not an intervention
- invasive fungal infections and leishmaniasis Amphotericin B and Streptomyces: one natural antifungal, different pharmaceutical forms Streptomyces nodosus makes amphotericin B itself. A liposomal injection carries that same molecule in a designed lipid structure, and the label warns that amphotericin products differ in pharmacology, exposure, and dosing. amphotericin B from Streptomyces fermentation — Source, not an intervention
How evidence and relationships are named
Evidence belongs to an exact use
- Supported for this exact use
- Moderate- or high-confidence human evidence or current authoritative guidance supports the named preparation, population, and outcome. This does not make it interchangeable with another product.
- Promising, uncertain
- Human results suggest benefit, but small studies, bias, inconsistency, short follow-up, or product differences leave important uncertainty.
- Human exposure studied
- Human pharmacokinetic, interaction, or safety data exist, but they do not establish clinical benefit for the claimed use.
- Traditional use recorded
- A credible monograph or historical source records use. This preserves history and practice; it is not a clinical efficacy finding.
- Preclinical only
- The support is from chemistry, cells, animals, or mechanism rather than reliable human outcomes.
- Not established or conflicting
- Reliable human evidence is absent, materially conflicting, or too indirect for the stated use.
- Evidence of harm
- Human poisoning, regulatory findings, or other strong evidence shows meaningful danger in the named material or use.
- Source, not an intervention
- The organism or physiological molecule explains the drug lineage but is not itself a usable treatment product.
A nature link is not automatically an alternative
- Same molecule occurs in nature
- Chemical identity may match, but purity, amount, formulation, route, companion compounds, and evidence can still differ.
- Direct natural precursor
- A natural molecule is chemically converted into the medicine or its immediate active form.
- Purified natural mixture
- A heterogeneous active material made by an organism is extracted, purified, assayed, and standardized; source identity and process remain part of the medicine.
- Historical industrial feedstock
- A natural material enabled manufacture through multiple chemical transformations; the final medicine does not occur in that source.
- Historical discovery lead
- Observation of a natural material or molecule helped reveal the drug family, without making the final medicine identical to the source.
- Nature-inspired scaffold
- The medicine retains a natural-product molecular scaffold after deliberate structural change; the exact manufacturing route and development aim require separate evidence.
- Similar target or mechanism
- The natural material affects some of the same biology, but it is chemically and clinically distinct.
- Studied for the same condition
- The interventions share a treatment goal; this alone says nothing about equal benefit, risk, or interchangeability.
- Traditional symptom overlap only
- A traditional use resembles part of a modern symptom description, but the diagnostic frameworks and evidence are not equivalent.
- No known direct relationship
- No defensible molecular or discovery lineage is known; a nearby herb is not invented merely to fill the card.
- Relationship uncertain
- The proposed link is disputed, indirect, or insufficiently documented and remains explicitly unsettled.
Agents can read the compact shelf at /api/remedies/index.json. Every detail card keeps claim-level source IDs and a dated review boundary. Corrections are welcome through the public issue door.